|
|
Post by slugworth008 on Oct 31, 2016 10:29:31 GMT -5
Good call on vdex but do they have any locations up and running yet? Yes, in California. Opened a wk or so ago. Thank you! |
|
|
|
Post by slugworth008 on Oct 31, 2016 10:31:20 GMT -5
I also wonder if the first failed launch along with other drug reps could be hurting adoption. Let me explain, the last launch saw Doctors not writing scripts because they believed MNKD/Afrezza was done. Now we have 2.0, but what is the growing concern we all have, not enough cash. So if I'm a competing drug rep, and I notice the doctor is or is thinking about Afrezza what do I say. I would say just in case you weren't aware they are pretty cash strapped and not sure how much longer it will be available. Don't believe me check it out yourself. So then the doctor either checks it out himself or becomes hesitant to write the prescription for fear of it going away. Just a thought! Yes, there is some truth to this. We'll need clarity soon how they expect to proceed with no cash. Well the US government has figured out how to run w/o cash - lol Maybe MNKD can do this as well....hello China...you listening? |
|
|
|
Post by mockingjay on Oct 31, 2016 11:07:47 GMT -5
Several people have posted about four month waiting times for endo appointments and until yesterday I took those claims with the proverbial grain of salt. I'm not a diabetic, but I may have osteoporosis, so my primary care doc referred me to an endo. Yesterday I called to make an appointment and was told that the first slot available was on February 27th -- exactly four months away. The lesson I take from this is that when it comes to getting a Rx for Afrezza or any other drug from an endo, "demanding it" may or may not work, but be prepared for a l-o-n-g wait to get the chance to make that demand. imagine that you need to wait for 4 months, and then you will have spirometry test (if the endo doesn't have spirometry test in house) and to see endo again in 4 months , and then you need to fight to get access to the insurance and the endo is afraid of the labels etc ... afrezza is not the problem, the system is the problem and that why we have such low scripts to date . |
|
|
|
Post by applogic on Nov 1, 2016 13:22:38 GMT -5
I've written before that my PCP had his nurse give me the spiro and was going to prescribe on my follow up the next week and then something happened where for over a year he suddently developed persistent alzheimers. Who makes it? What's it called again? Never heard of it. But he knew who his Sanofi rep was. This time around, I think the doctors may be waiting to see if he company will be around.
As for my endo visit, I waited 4 weeks, not 4 months. As for demanding it, the endo will not want to prescribe if your insurance doesn't cover - otherwise they're just wasting their time. I've sat there and had that conversation with my own endo. He didn't want to prescribe either until I confirmed my insurance covers. It bothers me to the heavens that Mannkind didn't distribute the discount cards to my endo. I had to go to the website. The company really should have sent those out either by mail ahead of time or put them in the hands of the hired sales team as an excuse to personally deliver but I could rant on endlessly about management does wrong.
|
|
|
|
Post by goyocafe on Nov 1, 2016 13:56:24 GMT -5
I've written before that my PCP had his nurse give me the spiro and was going to prescribe on my follow up the next week and then something happened where for over a year he suddently developed persistent alzheimers. Who makes it? What's it called again? Never heard of it. But he knew who his Sanofi rep was. This time around, I think the doctors may be waiting to see if he company will be around.
As for my endo visit, I waited 4 weeks, not 4 months. As for demanding it, the endo will not want to prescribe if your insurance doesn't cover - otherwise they're just wasting their time. I've sat there and had that conversation with my own endo. He didn't want to prescribe either until I confirmed my insurance covers. It bothers me to the heavens that Mannkind didn't distribute the discount cards to my endo. I had to go to the website. The company really should have sent those out either by mail ahead of time or put them in the hands of the hired sales team as an excuse to personally deliver but I could rant on endlessly about management does wrong.
Wouldn't it be interesting for a "whistle-blower" to step forward with irrefutable evidence of SNY tampering with doctors they call on in an attempt to squelch Afrezza prescriptions. |
|
|
|
Post by figglebird on Nov 1, 2016 13:57:05 GMT -5
I would count on it...it's already taking shape.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 1, 2016 13:57:19 GMT -5
I've written before that my PCP had his nurse give me the spiro and was going to prescribe on my follow up the next week and then something happened where for over a year he suddently developed persistent alzheimers. Who makes it? What's it called again? Never heard of it. But he knew who his Sanofi rep was. This time around, I think the doctors may be waiting to see if he company will be around.
As for my endo visit, I waited 4 weeks, not 4 months. As for demanding it, the endo will not want to prescribe if your insurance doesn't cover - otherwise they're just wasting their time. I've sat there and had that conversation with my own endo. He didn't want to prescribe either until I confirmed my insurance covers. It bothers me to the heavens that Mannkind didn't distribute the discount cards to my endo. I had to go to the website. The company really should have sent those out either by mail ahead of time or put them in the hands of the hired sales team as an excuse to personally deliver but I could rant on endlessly about management does wrong.
Did you email Mike and trying get an answer? |
|
|
|
Post by dreamboatcruise on Nov 1, 2016 14:07:51 GMT -5
I've written before that my PCP had his nurse give me the spiro and was going to prescribe on my follow up the next week and then something happened where for over a year he suddently developed persistent alzheimers. Who makes it? What's it called again? Never heard of it. But he knew who his Sanofi rep was. This time around, I think the doctors may be waiting to see if he company will be around.
As for my endo visit, I waited 4 weeks, not 4 months. As for demanding it, the endo will not want to prescribe if your insurance doesn't cover - otherwise they're just wasting their time. I've sat there and had that conversation with my own endo. He didn't want to prescribe either until I confirmed my insurance covers. It bothers me to the heavens that Mannkind didn't distribute the discount cards to my endo. I had to go to the website. The company really should have sent those out either by mail ahead of time or put them in the hands of the hired sales team as an excuse to personally deliver but I could rant on endlessly about management does wrong.
Wouldn't it be interesting for a "whistle-blower" to step forward with irrefutable evidence of SNY tampering with doctors they call on in an attempt to squelch Afrezza prescriptions. You make it sound as if that isn't common practice. |
|
|
|
Post by goyocafe on Nov 1, 2016 14:15:00 GMT -5
Wouldn't it be interesting for a "whistle-blower" to step forward with irrefutable evidence of SNY tampering with doctors they call on in an attempt to squelch Afrezza prescriptions. You make it sound as if that isn't common practice. Call me naive, but I would suspect that it's all relative. Considering SNY's unique position as a previous "partner" they may have a greater obligation not to bad mouth a drug they were suppose to promote just 12 months ago. If they're giving out misleading and damning information that is not accurate, I'd hope that a real smoking gun could be useful in demanding a settlement. Who knows, maybe I'm the drowning rat trying to cling on to anything that floats. I just realized I used that "hope" word again. Par for the course. |
|
|
|
Post by agedhippie on Nov 1, 2016 15:48:38 GMT -5
All the Sanofi rep needs to say on their next visit is, "Here are the new drugs that you might be interested in and we will withdrawing from these". They don't need to say more than that and that is perfect valid. If the doctor asks what will be happening they can just say they will be supplying it for 6 months and leave it at that. It's not the Sanofi rep's job to sell a competing drug.
|
|
|
|
Post by bioexec25 on Nov 1, 2016 16:33:39 GMT -5
Agree Aged. I believe most of the damage was perpetrated by the SNY sales force with talking points in Q4/Q1. Not a quote directly but they basically repeated the corp statement saying we tried and not enough commercial potential. That followed up by reps repeating it won't be available. I don't think the competition reps openly bash Afrezza these days, they simply don't need to anymore. The deed is mostly done in their minds.
Even though some encouragement recently by in large we still face manipulation , insurance woes, anemic scripts, debt/cash, emerging sense that a significant % of new patients don't stay on Afrezza, no label or protocol change. Basically not much has changed to remove the big barriers and 70 people are trying to sell against that backdrop.
I don't wax negative often and I still believe (holding not buying) it is possible to achieve a great deal of success with Afrezza if not Mannkind. But as Led Zeppelin sings "and our time is flying, see the candle burning low".
|
|
|
|
Post by mannmade on Nov 1, 2016 16:55:45 GMT -5
Which candle would that be?  Holding as well... |
|
|
|
Post by bioexec25 on Nov 1, 2016 17:05:19 GMT -5
Which candle would that be? Holding as well... Hehe. Candle analogy a reference to time left to get traction or fund more time. Guess that would be analogous to lighting a new candle. Ah anyway all good analogies break down when discussed in detail. :-)) |
|
|
|
Post by cjc04 on Nov 1, 2016 17:52:44 GMT -5
You make it sound as if that isn't common practice. Call me naive, but I would suspect that it's all relative. Considering SNY's unique position as a previous "partner" they may have a greater obligation not to bad mouth a drug they were suppose to promote just 12 months ago. If they're giving out misleading and damning information that is not accurate, I'd hope that a real smoking gun could be useful in demanding a settlement. Who knows, maybe I'm the drowning rat trying to cling on to anything that floats. I just realized I used that "hope" word again. Par for the course. I apologize, but I have to agree with your self assessment of being naive. SNY reps were talking sh"t about Afrezza while they were supposedly a partner. So now that they're a competitor...... With all these huge BP companies competing for time and space with endos and docs, ALL of which are threatened by Afrezza, I don't think MNKD ever had a chance of going alone. This is a nasty crooked business, and little ole MNKD with their temp hire 70 sales reps never had a chance, Especially with a label that prohibits them from talking about the greatest benefits of Afrezza. I always hoped that this was some sort of set up for a new partner or BO.... Sorry, I'm bitter, and is disbelief of where we are right now. |
|
|
|
Post by goyocafe on Nov 1, 2016 19:40:19 GMT -5
Call me naive, but I would suspect that it's all relative. Considering SNY's unique position as a previous "partner" they may have a greater obligation not to bad mouth a drug they were suppose to promote just 12 months ago. If they're giving out misleading and damning information that is not accurate, I'd hope that a real smoking gun could be useful in demanding a settlement. Who knows, maybe I'm the drowning rat trying to cling on to anything that floats. I just realized I used that "hope" word again. Par for the course. I apologize, but I have to agree with your self assessment of being naive. SNY reps were talking sh"t about Afrezza while they were supposedly a partner. So now that they're a competitor...... With all these huge BP companies competing for time and space with endos and docs, ALL of which are threatened by Afrezza, I don't think MNKD ever had a chance of going alone. This is a nasty crooked business, and little ole MNKD with their temp hire 70 sales reps never had a chance, Especially with a label that prohibits them from talking about the greatest benefits of Afrezza. I always hoped that this was some sort of set up for a new partner or BO.... Sorry, I'm bitter, and is disbelief of where we are right now. No apology necessary. It is what it is. I was simply putting some value in the possibility that if it were that blatant (or if there truly was a smoking gun) that an "unbiased" arbitration panel would have an easier time seeing its way to levying a settlement in MNKD's favor. |
|
Holding as well...